Szabo, Gyorgy published the artcileMultiparameter Optimization of Naphthyridine Derivatives as Selective α5-GABAA Receptor Negative Allosteric Modulators, Name: 2-Bromoethyl Methyl Sulfone, the publication is Journal of Medicinal Chemistry (2022), 65(11), 7876-7895, database is CAplus and MEDLINE.
The discovery and characterization of novel naphthyridine derivatives with selective α5-GABAAR neg. allosteric modulator (NAM) activity are disclosed. Utilizing a scaffold-hopping strategy, fused [6 + 6] bicyclic scaffolds were designed and synthesized. Among these, 1,6-naphthyridinones were identified as potent and selective α5-GABAAR NAMs with metabolic stability, cardiac safety, and beneficial intellectual property (IP) issues. Relocation of the oxo acceptor function and subsequent modulation of the physicochem. properties resulted in novel 1,6-naphthyridines with improved profile, combining good potency, selectivity, ADME, and safety properties. Besides this, compound 20 (I), having the most balanced profile, provided in vivo proof of concept (POC) for the new scaffold in two animal models of cognitive impairment associated with schizophrenia (CIAS).
Journal of Medicinal Chemistry published new progress about 16523-02-7. 16523-02-7 belongs to bromides-buliding-blocks, auxiliary class Bromide,Sulfone,Aliphatic hydrocarbon chain, name is 2-Bromoethyl Methyl Sulfone, and the molecular formula is C8H11NO, Name: 2-Bromoethyl Methyl Sulfone.
Referemce:
https://en.wikipedia.org/wiki/Bromide,
bromide – Wiktionary